Description
Diazepam by Teva Pharmaceutical Industries
Diazepam, produced by Teva Pharmaceutical Industries, is one of the most widely distributed generic benzodiazepine products in global pharmaceutical markets. Teva is the world’s largest manufacturer of generic medicines, supplying thousands of pharmaceutical products across more than 60 countries. The company manufactures diazepam tablets within its extensive generic drug portfolio, which includes treatments across neurology, respiratory medicine, oncology, and central nervous system therapeutics.
Teva’s diazepam tablets are distributed through regulated pharmacy networks and licensed wholesalers. The company operates multiple manufacturing facilities that produce high-volume generic medicines while maintaining regulatory compliance with authorities, including the U.S. Food and Drug Administration and the European Medicines Agency.
Company Background and Scale
Teva Pharmaceutical Industries was founded in 1901 in Jerusalem. Over the past century, the company expanded through acquisitions and global partnerships, becoming the dominant producer of generic medicines worldwide.
Several milestones define Teva’s position in the pharmaceutical industry:
The company produces over 3,500 medicines globally
Generic medicines manufactured by Teva are used by hundreds of millions of patients each year
Teva operates 40+ manufacturing facilities worldwide
The company distributes medicines to 60+ countries
Annual revenue has exceeded $15 billion in recent financial reports
Teva’s generics portfolio includes widely prescribed medicines such as diazepam, clonazepam, and other central nervous system medications. High-volume production enables large-scale distribution to pharmacies, hospitals, and healthcare systems.
What are The Specifications of Teva Diazepam?
| Attribute | Detail |
|---|---|
| Active ingredient | Diazepam |
| Manufacturer | Teva Pharmaceutical Industries |
| Headquarters | Tel Aviv, Israel |
| Global distribution | 60+ countries |
| Regulatory oversight | FDA, EMA and other national regulators |
| Packaging format | Pharmaceutical blister packs or bottles depending on market |
Teva’s diazepam tablets are manufactured using validated formulation processes designed to maintain uniform dosage and pharmaceutical stability across large production volumes.
Manufacturing and Regulatory Oversight
Teva operates under strict regulatory frameworks across multiple jurisdictions. Facilities producing diazepam are inspected by international regulators to ensure compliance with Good Manufacturing Practice (GMP) requirements.
Key manufacturing controls include:
Controlled ingredient sourcing
Batch-level analytical testing
Dissolution and potency verification
Environmental monitoring in production areas
Stability testing for long-term shelf life
These processes ensure consistency between batches distributed to pharmacies across different regions.
Market Presence in the Generic Medicine Sector
Teva plays a central role in the global generic drug market. The company supplies medications to national healthcare systems, hospital networks, and retail pharmacies.
According to pharmaceutical industry reports:
Teva accounts for one of the largest shares of the global generic medicines market
In the United States alone, 1 in every 10 generic prescriptions is filled with a Teva product
The company’s medicines are used by over 200 million patients annually
Because diazepam has been off-patent for decades, multiple manufacturers produce it. Teva remains one of the most recognised producers due to its scale and established distribution network.
Why Should You Buy Teva Diazepam?
Manufactured by the largest generic drug producer globally
Distributed across North America, Europe, and Asia
Produced in facilities inspected by major regulatory authorities
Supplied to hospital systems and pharmacy chains worldwide
These factors contribute to the brand recognition of Teva’s generic medicines among healthcare providers and pharmacies.
FAQs
How large is Teva’s pharmaceutical production network?
Teva operates over 40 manufacturing facilities worldwide. These plants produce thousands of medicines each year across multiple therapeutic areas. The scale of production allows Teva to supply large healthcare systems and pharmacy networks consistently.
How are Teva pharmaceutical products regulated?
Teva facilities are regularly inspected by regulatory authorities such as the U.S. Food and Drug Administration and the European Medicines Agency. These inspections verify compliance with Good Manufacturing Practice standards, which cover manufacturing conditions, quality testing, and documentation procedures.
How can pharmacies verify the authenticity of Teva diazepam?
Authentic products include identifiable packaging with Teva branding, batch numbers, and expiry dates. Pharmacies source medicines through licensed wholesalers and distributors that maintain supply chain verification to prevent counterfeit products entering regulated markets.
